Larimar Therapeutics, Inc. (LRMR) — Financial ratios
Profitability, liquidity, leverage, and valuation ratios for Larimar Therapeutics, Inc., with annual and quarterly history.
| Metric | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 |
|---|---|---|---|---|---|---|
| Valuation | ||||||
| P/E Ratio | -1.68x | -2.94x | -5.41x | -3.01x | -3.66x | -6.01x |
| P/B Ratio | 3.56x | 1.38x | 2.44x | 0.96x | 2.88x | 2.84x |
| P/S Ratio | 0.00x | 0.00x | 0.00x | 0.00x | 0.00x | 0.00x |
| Profitability | ||||||
| Gross Margin | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% |
| Operating Margin | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% |
| Net Margin | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% |
| EBITDA Margin | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% |
| Liquidity | ||||||
| Current Ratio | 2.19x | 8.02x | 9.49x | 11.28x | 8.16x | 10.89x |
| Quick Ratio | 2.19x | 8.02x | 9.49x | 11.28x | 8.16x | 10.89x |
| Leverage | ||||||
| Debt/Equity | 0.05x | 0.03x | 0.07x | 0.05x | 0.09x | 0.07x |
YoY = year-over-year change. Source: FMP..